Nymox Pharmaceutical Market Cap

Nymox Pharmaceutical has a market cap or net worth of $5.41 million as of January 23, 2026. Its market cap has increased by 15.63% in one year.

Market Cap

5.41M

Enterprise Value

8.62M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.05

Market Cap Chart

Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 5.41M, a decrease of -95.42%. That is a compound annual growth rate of -10.37%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2026	5.41M	31.84%
Dec 31, 2025	4.10M	-56.61%
Dec 31, 2024	9.45M	-82.82%
Dec 29, 2023	55.03M	86.49%
Dec 30, 2022	29.51M	-73.23%
Dec 31, 2021	110.23M	-42.54%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Biomind Labs	8.84M
Zenith Capital	7.99M
NKGen Biotech	7.84M
Curative Biotechnology	7.47M
Synlogic	7.25M
Brainstorm Cell Therapeutics	6.51M
Bioxytran	6.46M
BetterLife Pharma	5.48M

Market Cap Rankings